manilatimes1d
Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma
Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC. Amezalpat builds ...
Daily4d
Hepatocellular Carcinoma After Hepatitis C Cure: Study Emphasizes The Need for Long-Term Surveillance
China: A recent study published in the Annals of Hepatology has emphasized the influence of age on hepatocellular carcinoma ...
Frontiers4d
Using Oncolytic Viruses in Cancer Immunity and Immunotherapy: Hepatocellular Carcinoma, Gastric Cancer, and Colorectal Cancer
Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...
EurekAlert!5d
Two surgeon-scientists receive top national research awards to improve outcomes for SG-prevalent liver and head & neck cancers
Investigator Award has been awarded to two surgeon-scientists at the National Cancer Centre Singapore (NCCS) to pursue novel research in liver cancer and head and neck cancers. Globally, liver cancer ...
Triple Negative Breast Cancer FDA Approvals, Emerging Therapies, Pipeline Insights and Companies | DelveInsight
The leading Triple Negative Breast Cancer Companies such as Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 ...
Life Science Leader6d
Companies To Watch: Senti Bio
Senti Bio aims to improve cancer therapeutics with customizable gene circuits, or multi-gene constructs capable of ...
Bristol-Myers Squibb: Cobenfy's Strong Launch And 2025 Growth Outlook
Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...
Frontiers4d
Novel Therapeutic Approaches for Biliary Tract Cancer and Hepatocellular Carcinoma, Volume II
Building on the great success of the Research Topic “Novel Therapeutic Approaches for Biliary Tract Cancer and Hepatocellular Carcinoma” the launch of this second volume aims to further bridge the gap ...
Science Daily3h
Candidate genes in canine hepatocellular carcinoma for molecular targeted therapy
Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...
AZoLifeSciences on MSN5d
Researchers Identify Key Mechanism in Transformation of Stem Cells to Cancer Cells
Nearly 60,000 people are diagnosed with oral cancer in the U.S. every year, according to the American Cancer Society, and the rate of new cases continues to rise.